Blockchain Registration Transaction Record

BioXgen Unveils Cardiac Patch in Investor Webinar, Opens Crowdfunding

BioXgen announces a Regulation Crowdfunding investment offering and live webinar for its cardiac patch to prevent post-operative atrial fibrillation after open-heart surgery.

This news matters because it highlights a potential breakthrough in preventing a common and serious complication of open-heart surgery, affecting nearly 250,000 Americans annually. Postoperative atrial fibrillation (POAF) increases hospital stays, healthcare costs, and patient risks, yet no FDA-approved device currently exists to prevent it. BioXgen's cardiac patch, backed by clinical data showing a dramatic reduction in POAF rates, could significantly improve recovery outcomes and reduce medical burdens. For investors, it offers an opportunity to support an innovative medical technology with clear market demand and regulatory progress, potentially transforming cardiac care and offering financial returns as the company moves toward commercialization.